About HekaBio K.K.
We are an asset-light, emerging commercial-stage biopharma and MedTech venture that in-license early, de-risked assets to commercialize in Japan and the APAC region.
Headquarters
Chuo-ku, TokyoWebsite
https://www.heka.bioCompany Size
11-50 employeesIndustry
Biotechnology ResearchCompany Type
Privately HeldFounded
2025Specialties
Oncology, Clinical development, Regulatory development, Commercialization, Medical Device, Reimbursement, Pharmaceuticals, Business Development, Bioventure, Cardiology, CNS, Ophthalmology, BD&L, Pharmaceutical In-Licensing, and Medical Device In-Licensing